November 3, 2009 (Chicago, Illinois) — In patients with head and neck squamous cell carcinoma (HNSCC), high p16 antibody expression might serve as a marker for infection with high-risk human ...
Given the strong prognostic implications of both p16 IHC and HPV status for OP tumors, Chung et al, 17 in the article that accompanies this editorial, pose an important follow-up question: What are ...
Treatment deintensification for human papillomavirus–positive (HPV+)-associated oropharyngeal cancer (OPC) has been the catalyst of experts worldwide. In situ hybridization is optimal to identify HPV+ ...
Please provide your email address to receive an email when new articles are posted on . The addition of cetuximab to radiotherapy appeared to improve clinical outcomes for patients with locoregionally ...
Patients with head and neck cancer are now routinely tested for human papillomavirus (HPV), as disease associated with the virus has a different prognosis and different treatment than disease not ...
A recent study finds patients who test positive for an HPV biomarker may not be positive for HPV itself, and these patients see significantly lower five-year survival rates. Oropharyngeal cancer is ...
Patients who have head and neck cancer caused by the human papilloma virus should be double tested, after new research solves puzzle over worsening outcomes among some people. A major international ...
Please provide your email address to receive an email when new articles are posted on . D’Souza and colleagues collected data from a stratified random sample of 863 patients (64% male; median age, 58 ...
When it comes to cancer-causing viruses like human papillomavirus, or HPV, researchers are continuing to find that infection with one strain may be better than another. In an analysis of survival data ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback